Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches.

Area of Science:

• Pharmacology and Experimental Design
• Drug Discovery and Development

Background:

• Traditional drug development relies on steady-state analyses, which may not be the most efficient method.
• Minimizing patient or animal exposure, time, and cost are crucial in drug development.

Purpose of the Study:

• To explore study designs that extract maximum information from experiments.
• To reduce patient/animal exposure and experimental costs in drug development.

Main Methods:

• Investigating within-individual dose escalation.
• Analyzing responses as drug concentrations decline within individuals.
• Comparing these methods to steady-state cross-sectional analyses.

Main Results:

• Within-individual approaches can yield more information efficiently.
• These methods reduce the need for extensive cross-sectional studies.
• Potential for significant time and cost savings in drug development.

Conclusions:

• Novel study designs focusing on within-individual responses offer a more efficient paradigm for drug development.
• These methods align with ethical considerations for reduced exposure and resource optimization.